JP2011512817A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512817A5
JP2011512817A5 JP2010548830A JP2010548830A JP2011512817A5 JP 2011512817 A5 JP2011512817 A5 JP 2011512817A5 JP 2010548830 A JP2010548830 A JP 2010548830A JP 2010548830 A JP2010548830 A JP 2010548830A JP 2011512817 A5 JP2011512817 A5 JP 2011512817A5
Authority
JP
Japan
Prior art keywords
clostridium difficile
binds
isolated antibody
protein
acetylmuramoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010548830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512817A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/035050 external-priority patent/WO2009108652A1/en
Publication of JP2011512817A publication Critical patent/JP2011512817A/ja
Publication of JP2011512817A5 publication Critical patent/JP2011512817A5/ja
Pending legal-status Critical Current

Links

JP2010548830A 2008-02-28 2009-02-25 クロストリジウム・ディフィシル胞子に対する抗体及びその使用 Pending JP2011512817A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3227008P 2008-02-28 2008-02-28
PCT/US2009/035050 WO2009108652A1 (en) 2008-02-28 2009-02-25 Antibodies to clostridium difficile spores and uses thereof

Publications (2)

Publication Number Publication Date
JP2011512817A JP2011512817A (ja) 2011-04-28
JP2011512817A5 true JP2011512817A5 (enExample) 2012-04-12

Family

ID=41016450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010548830A Pending JP2011512817A (ja) 2008-02-28 2009-02-25 クロストリジウム・ディフィシル胞子に対する抗体及びその使用

Country Status (9)

Country Link
US (2) US8697374B2 (enExample)
EP (1) EP2271366A4 (enExample)
JP (1) JP2011512817A (enExample)
KR (1) KR20100126760A (enExample)
CN (1) CN101980723A (enExample)
AU (1) AU2009219358A1 (enExample)
BR (1) BRPI0906060A2 (enExample)
CA (1) CA2714720A1 (enExample)
WO (1) WO2009108652A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102388064A (zh) * 2009-03-27 2012-03-21 高裘企业公司 用于筛选与使用拮抗孢子-表面交互作用的化合物的组合物与方法
CN102533867A (zh) * 2010-12-10 2012-07-04 西北民族大学 一种艰难梭菌a毒素的类毒素的制备方法
US10295535B2 (en) * 2011-04-29 2019-05-21 Techlab, Inc. Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease
US20120276059A1 (en) 2011-04-29 2012-11-01 Techlab, Inc. Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
EP2755681B1 (en) * 2011-09-15 2018-06-27 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH
WO2013038156A1 (en) * 2011-09-16 2013-03-21 Ucb Pharma S.A. Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
CA2856085C (en) 2011-11-18 2020-06-30 National Research Council Of Canada Clostridium difficile lipoteichoic acid and uses thereof
CN102590515B (zh) * 2012-01-13 2014-07-30 张春华 艰难梭菌外毒素a检测试剂盒及组成该试剂盒的单克隆抗体
RU2628305C2 (ru) 2012-03-02 2017-08-15 Регенерон Фармасьютиказ, Инк. Человеческие антитела к токсинам clostridium difficile
US9133527B2 (en) * 2012-05-11 2015-09-15 Techlab, Inc. Cell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
BR112015004629A2 (pt) * 2012-09-19 2017-11-21 Novartis Ag polipeptídeos de clostridium difficile como vacinas
JP2016501877A (ja) * 2012-11-28 2016-01-21 シーエヌジェー ホールディングス,インコーポレイテッド クロストリジウム・ディフィシルに対する抗体
CN105555309A (zh) * 2013-04-19 2016-05-04 英穆伦有限公司 治疗和/或预防艰难梭菌相关疾病的方法和组合物
WO2015150493A1 (en) * 2014-04-01 2015-10-08 Institut Pasteur Predictive value of clostridium difficile-specific immune response for recurrence and disease outcome
WO2015191419A2 (en) 2014-06-09 2015-12-17 3M Innovative Properties Company Assay devices and method of detecting a target analyte
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
US20190059860A1 (en) * 2015-09-21 2019-02-28 4C Diagnostics Ltd. Stool specimen collecting, sampling and diagnosing means and methods thereof
JP2022535131A (ja) 2019-06-05 2022-08-04 リブ・プロセス・インコーポレイテッド クロストリジウム・ディフィシル菌に対するアプタマー
CN111948388B (zh) * 2020-08-18 2022-03-22 山东农业大学 一种检测腐败梭菌的胶体金试纸条及其制备方法和应用
EP4398890A4 (en) 2021-09-09 2025-07-30 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The Univ Of Nevada Las Ve C. Difficile Spore Germination Inhibitors
CN119751687B (zh) * 2024-12-26 2025-09-26 杭州医学院 识别艰难梭菌谷氨酸脱氢酶中线性b细胞抗原表位的驼源单域抗体ga4及应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879218A (en) 1982-09-13 1989-11-07 Virginia Tech Intellectual Properties, Inc. Antibody for C.difficile
US4530833A (en) 1982-09-13 1985-07-23 Wilkins Tracy D Toxins and antibodies of C. difficile
US4533630A (en) 1982-09-13 1985-08-06 Wilkins Tracy D Toxins and antibodies of C. difficile
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8426464D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US4863852A (en) 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
EP1997891A1 (en) 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5231003A (en) 1990-05-11 1993-07-27 Cambridge Bioscience Corporation Monoclonal antibodies specific for toxin b of clostridium difficile
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
ATE439435T1 (de) 1991-03-01 2009-08-15 Dyax Corp Chimäres protein mit mikroprotein mit zwei oder mehr disulfidbindungen und ausgestaltungen davon
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5610023A (en) 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US7179611B2 (en) 1997-02-10 2007-02-20 Bd Lee Laboratories Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A
US5965375A (en) 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
AU8395498A (en) * 1997-07-11 1999-02-08 Regents of The University of Arizona, The Hen egg yolk antibodies to (clostridium difficile) antigens and use in therapy for pseudomembranous colitis
US5876960A (en) 1997-08-11 1999-03-02 The United States Of America As Represented By The Secretary Of The Army Bacterial spore detection and quantification methods
US6733760B1 (en) 1999-04-09 2004-05-11 Techlab, Inc. Recombinant toxin A/toxin B vaccine against Clostridium difficile
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
ES2258483T3 (es) 1999-11-01 2006-09-01 Mucovax Holding B.V Produccion de anticuerpos de secrecion mamaria en animales de granja.
US6509196B1 (en) 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
GB0007263D0 (en) 2000-03-24 2000-05-17 Imperial College Peptides
US6498041B1 (en) 2000-08-18 2002-12-24 Echo Technologies, Inc. Optical sensors for rapid, sensitive detection and quantitation of bacterial spores
US6815178B1 (en) 2001-11-19 2004-11-09 Antony R. Shoaf Endospore detection method
AU2002366448A1 (en) 2001-11-30 2003-09-02 California Institute Of Technology An improvement in a method bacterial endospore quantification using lanthanide dipicolinate luminescence
US7428045B2 (en) 2002-01-10 2008-09-23 Chemimage Corporation Raman spectral analysis of pathogens
US20040014154A1 (en) 2002-02-01 2004-01-22 Adrian Ponce Methods and apparatus for assays of bacterial spores
US20030175318A1 (en) 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
US20040033546A1 (en) * 2002-04-10 2004-02-19 The Trustees Of Columbia University In The City Of New York Novel microarrays and methods of use thereof
US7608419B2 (en) 2003-11-13 2009-10-27 California Institute Of Technology Method and apparatus for detecting and quantifying bacterial spores on a surface
WO2004069848A2 (en) 2003-01-28 2004-08-19 Diversa Corporation Amidases, nucleic acids encoding them and methods for making and using them
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US20060275920A1 (en) 2005-06-01 2006-12-07 Petrilla John F Apparatus and method for discriminating among lateral flow assay test indicators

Similar Documents

Publication Publication Date Title
JP2011512817A5 (enExample)
WO2011153300A3 (en) Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
JP2010143932A5 (enExample)
JP2010115195A5 (enExample)
WO2011055968A3 (en) Kit for detecting bacterial infection comprising novel monoclonal antibodies
ZA201000093B (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
WO2010010466A3 (en) Neutralizing anti-influenza a virus antibodies and uses thereof
WO2011005357A3 (en) Immunogenicity assay
JP2010539161A5 (enExample)
WO2008070229A3 (en) Detection of pathogenic aggregates of protein in a sample by homologous elisa
JP2018033454A5 (enExample)
WO2009031045A3 (en) Anti-chikungunya monoclonal antibodies and uses thereof
WO2012017466A8 (en) Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
AR098126A1 (es) Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos
EP2577307A4 (en) DIAGNOSTIC TEST
WO2006086799A3 (en) Prion-specific peptide reagents
MX2014010068A (es) Metodos y sistemas para amplificacion de señal de bioensayos.
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection
WO2011003598A3 (de) Detektion von antigenen
WO2018068064A3 (en) Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
JP2014524583A5 (enExample)
FR2896588B1 (fr) Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
WO2010123283A3 (ko) 형광 표지된 코히신 마커 및 그것을 이용한 셀룰로좀 형성 효소 탐색방법